Proteros Biostructures Achieve Milestone in Fragment-Based Protein Crystallography Collaboration
News Jun 21, 2007
Proteros biostructures GmbH has announced that the first milestone of their research collaboration with Bayer HealthCare in the field of fragment-based protein crystallography has been successfully achieved, triggering the associate milestone payment.
In the collaboration, which started in June 2006, Proteros applies its target know-how, industrial process and proprietary Free Mounting System (FMS™) and Picodropper™ technologies to deliver protein-ligand-structures of active fragments from Bayer HealthCare’s drug discovery programs to Bayer HealthCare. Under the terms of the agreement Proteros will also receive a copy of the jointly selected fragment library for its own use.
”We are pleased to proof that Proteros’ experience, has allowed delivery of valuable protein-fragment-structures to Bayer HealthCare within the envisioned time frame”, stated Torsten Neuefeind, Ph.D., Chief Executive Officer of Proteros.
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
Empowering Women in Technology Key to Boosting UK EconomyNews
A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.READ MORE
Pain's Origins May Be Significantly Different in Males and FemalesNews
Researchers found that a specific manipulation of receptors in the nervous system for the neurotransmitter dopamine impairs chronic pain in male mice, but has no effect on females.READ MORE